|
|
|
|
| LEADER |
02440nam a22003375i 4500 |
| 001 |
000288958 |
| 005 |
20210909132930.0 |
| 007 |
cr nn 008mamaa |
| 008 |
151021s2015 ja | s |||| 0|eng d |
| 020 |
|
|
|a 9784431545415
|
| 024 |
7 |
|
|a 10.1007/978-4-431-54541-5
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Neurodegenerative Disorders as Systemic Diseases /
|c edited by Keiji Wada.
|
| 250 |
|
|
|a 1st ed. 2015.
|
| 260 |
# |
# |
|a Tokyo :
|b Springer Japan :
|b Imprint: Springer,
|c 2015.
|
| 300 |
|
|
|a VIII, 304 p. 34 illus., 19 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a PART I A NEW CONCEPT OF NEURODEGENERATION IN BIOLOGY AND PATHOPHYSIOLOGY -- 1 Conformational disease and RNA disease theory in the context of neurodegenerative diseases -- 2 Brain-peripheral organ communication -- 3 The brain-immune network in spinal cord injury -- PART II CHANGES IN CLINICAL EVALUATION AND NEW BIOMARKERS -- 4 Renovation of clinical evaluation and new biomarkers -- 5 Clinical Systems Neuroscience -- PART III RISK FACTORS IN NEURODEGENERATION -- 6 Genetic risk factors for neurodegenerative diseases -- 7 Intermediate phenotypes approach for neuropsychiatric disorders -- PART IV FUTURE DIRECTIONS FOR THERAPY -- 8 Significance of mechanism-oriented research toward neuronal protection therapy against neurodegenerative disorders ~ ZNRF1 E3 ubiquitin ligase as a critical mediator for Wallerian degeneration and neuronal apoptosis -- 9 Drug development for neurodegenerative diseases -- 10 Physical therapy and rehabilitation in patients with degenerative cerebellar diseases: current evidence and future direction -- 11 Home- and Community-based medical care for neurodegenerative diseases -ALS as an illustration- -- PART V HEALTH PROMOTION: PREVENTION AND QUALITY OF LIFE -- 12 Information Environment and Brain Function: A New Concept of the Environment for the Brain -- 13 Social Implementation of Neurodegenerative Disease Research and Neuroethics.-.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Psychiatry.
|
| 650 |
|
0 |
|a Neurobiology.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Psychiatry.
|
| 650 |
2 |
4 |
|a Neurobiology.
|
| 700 |
1 |
|
|a Wada, Keiji.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|